Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors
暂无分享,去创建一个
Walter Cabri | Sergio Penco | Grazia Gallo | Giuseppe Giannini | Arianna Quintavalla | G. Giannini | W. Cabri | A. Quintavalla | Silvia Vincenti | Paola Galletti | Caterina Ventrici | Daria Giacomini | P. Galletti | S. Penco | D. Giacomini | G. Gallo | Caterina Ventrici | S. Vincenti | Daria Giacomini
[1] A. Mirsky,et al. ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[2] R. H. Schlessinger,et al. A novel method of preparing alpha-substituted hydracrylate and acrylate esters , 1973 .
[3] T. Aida,et al. Cyclization reactions of 4-(3′-butenyl)azetidin-2-one a route to the carbopenam ring system , 1979 .
[4] H. Hoberg,et al. Stöchiometrische und katalytische CC-verknüpfungen zwischen 1,3-butadien und phenylisocyanat an nickel(0)-komplexen , 1987 .
[5] J. Clark,et al. Cloning and characterization of a novel human histone deacetylase, HDAC8. , 2000, The Biochemical journal.
[6] James D. Winkler,et al. Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor* , 2000, The Journal of Biological Chemistry.
[7] V. Kiermer,et al. The emerging role of class II histone deacetylases. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[8] M. Konaklieva. β-Lactams as Inhibitors of Serine Enzymes , 2002 .
[9] Ricardo Macarron,et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases , 2003, Journal of Pharmacology and Experimental Therapeutics.
[10] M. Mori,et al. Synthesis of 3-alkoxycarbonyl-1beta-methylcarbapenem by using the palladium-catalyzed C-N bond-forming reaction between vinyl halide and beta-lactam nitrogen. , 2003, The Journal of organic chemistry.
[11] T. Kummalue,et al. The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain , 2003, Molecular and Cellular Biology.
[12] L. Schwartz,et al. Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] E. Lukevics,,et al. Design of β-lactams with mechanism based nonantibacterial activities , 2003 .
[14] R. De Francesco,et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] V. Castronovo,et al. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. , 2004, The American journal of pathology.
[16] J. R. Somoza,et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.
[17] Ivan V. Gregoretti,et al. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.
[18] T. A. Ayers,et al. Diastereoselective alkylation of beta-amino esters: structural and rate studies reveal alkylations of hexameric lithium enolates. , 2004, Journal of the American Chemical Society.
[19] F. Becker,et al. Synthesis of anticancer β-lactams: mechanism of action , 2004 .
[20] Eric Verdin,et al. Histone deacetylase HDAC8 associates with smooth muscle α‐actin and is essential for smooth muscle cell contractility , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] K. Bhalla. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. Garbisa,et al. 4-Alkyliden-beta-lactams conjugated to polyphenols: synthesis and inhibitory activity. , 2005, Bioorganic & medicinal chemistry.
[23] G. Giannini,et al. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity. , 2005, Journal of medicinal chemistry.
[24] H. Pritzkow,et al. Bridging β‐Lactam Coordination at Dinuclear Zinc Sites , 2005 .
[25] G. Musumarra,et al. Design, synthesis, and biological evaluation of 4-alkyliden-beta lactams: new products with promising antibiotic activity against resistant bacteria. , 2006, Journal of medicinal chemistry.
[26] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[27] S. Garbisa,et al. Inhibition of Leukocyte Elastase, Polymorphonuclear Chemoinvasion, and Inflammation-Triggered Pulmonary Fibrosis by a 4-Alkyliden-β-lactam with a Galloyl Moiety , 2006, Journal of Pharmacology and Experimental Therapeutics.
[28] R. Ficner,et al. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases. , 2006, Journal of biotechnology.
[29] E. Seto,et al. Histone Deacetylase 8 Safeguards the Human Ever-Shorter Telomeres 1B (hEST1B) Protein from Ubiquitin-Mediated Degradation , 2006, Molecular and Cellular Biology.
[30] Ravi Varala,et al. Molecular iodine-catalyzed efficient N-Cbz protection of amines , 2007 .
[31] R. Johnstone,et al. Histone deacetylase inhibitors in cancer therapy , 2007, Expert opinion on investigational drugs.
[32] R. De Francesco,et al. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex , 2007, EMBO reports.
[33] Michele Pallaoro,et al. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics , 2007, Cell Research.
[34] Eric Verdin,et al. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[35] B. Långström,et al. Synthesis of [11C]/[13C]acrylamides by palladium-mediated carbonylation , 2007 .
[36] R. Deana,et al. Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation , 2007, Platelets.
[37] Seikwan Oh,et al. Synthesis of New β-Lactam Analogs and Evaluation of Their Histone Deacetylase (HDAC) Activity , 2007 .
[38] Y. Oda,et al. Expression profile of class I histone deacetylases in human cancer tissues. , 2007, Oncology reports.
[39] J. Buggy,et al. Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation , 2008, Leukemia.
[40] Di Chen,et al. Anti-tumor activity of N-thiolated beta-lactam antibiotics. , 2008, Cancer letters.
[41] M. K. Pflum,et al. Isoform-selective histone deacetylase inhibitors. , 2008, Chemical Society reviews.
[42] J. Marchand-Brynaert,et al. 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[43] S. Hrelia,et al. New Polyphenolic β‐Lactams with Antioxidant Activity , 2008, Chemistry & biodiversity.
[44] P. Wipf,et al. Titanocene(III)-catalyzed formation of indolines and azaindolines. , 2008, Organic letters.
[45] F. Zunino,et al. Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. , 2009, European journal of medicinal chemistry.
[46] G. Giannini,et al. N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[47] Barbara Hero,et al. Histone Deacetylase 8 in Neuroblastoma Tumorigenesis , 2009, Clinical Cancer Research.
[48] G. Giannini,et al. Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.